Fair Followers: Expanding Access to Generic Pharmaceuticals for Low- and Middle-Income Populations
Boston University School of Law
THE POWER OF PILLS, Jillian Clare Cohen, Patricia Illingworth, Udo Schuklenk, eds., University of Michigan Press, 2005
On innovation grounds, pharmaceutical patents are unnecessary in low income populations, since such markets cannot do much to support global pharmaceutical profits. The public health needs of low income populations require patented drugs to be manufactured at the marginal cost of production, without R&D cost recovery. Nonrivalrous access to pharmaceutical knowledge achieves both goals simultaneously.
Number of Pages in PDF File: 16
Keywords: pharmaceutical, pricing, patents, innovation, nonrivalrous, access, developing countries, low income countries
JEL Classification: H41, H51, I18, K11, K19, K32, K33Accepted Paper Series
Date posted: June 17, 2006
© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo2 in 0.360 seconds